Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells <i>in vivo</i> and <i>in vitro</i> by activating AMP-activated protein kinase

Abstract

Metformin attenuates the fibrogenic response of HSCs <i>in vivo</i> and <i>in vitro</i>, and may therefore be useful for the treatment of chronic liver diseases.